Please use this identifier to cite or link to this item:
https://repository.monashhealth.org/monashhealthjspui/handle/1/49502
Title: | Zanubrutinib, Alone and in Combination with Tislelizumab, for the Treatment of Richter Transformation of Chronic Lymphocytic Leukemia. | Authors: | Tam C.;Munoz J.;Cull G.;Opat S. ;Allewelt H.;Zhang X.;Stern J.C.;Hilger J.;By K.;Cohen A.;Tedeschi A. | Institution: | (Tam) Alfred Hospital and Monash University, Melbourne, VIC, Australia (Munoz) Banner MD Anderson Cancer Center, Gilbert, AZ, United States (Cull) Sir Charles Gairdner Hospital, Perth, WA, Australia (Cull) University of Western Australia, Perth, WA, Australia (Opat) Monash Health, Clayton, VIC, Australia (Opat) Monash University, Clayton, VIC, Australia (Allewelt, Zhang, Stern, Hilger, By, Cohen) BeiGene, San Mateo, CA, United States (Tedeschi) ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy |
Issue Date: | 30-Mar-2023 | Copyright year: | 2023 | Publisher: | Wolters Kluwer Health | Place of publication: | United States | Publication information: | HemaSphere. 7(4) (pp E870), 2023. Date of Publication: 24 Apr 2023. | Journal: | HemaSphere | DOI: | http://monash.idm.oclc.org/login?url=https://dx.doi.org/10.1097/HS9.0000000000000870 | URI: | https://repository.monashhealth.org/monashhealthjspui/handle/1/49502 | Type: | Letter | Subjects: | chronic lymphatic leukemia tislelizumab zanubrutinib |
Type of Clinical Study or Trial: | Opinion, perspective or news |
Appears in Collections: | Articles |
Show full item record
Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.